Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Low Grade Serous Ovarian Cancer × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 196 Uterine Cervical Neoplasms 161 Fallopian Tube Neoplasms 82 Carcinoma, Ovarian Epithelial 74 Endometrial Neoplasms 66 Neoplasms 34 Papillomavirus Infections 30 Uterine Cervical Dysplasia 29 Vulvar Neoplasms 22 Breast Neoplasms 22 Peritoneal Neoplasms 21 Condylomata Acuminata 19 Vaginal Neoplasms 17 Recurrence 14 Testicular Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Brenner Tumor 11 Burkitt Lymphoma 10 Sarcoma 9 Primary Myelofibrosis 9 Parkinson Disease 4, Autosomal Dominant Lewy Body 9 Multiple Myeloma 9 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Large B-Cell, Diffuse 9 Lymphoma, Follicular 9 Lymphoma, B-Cell, Marginal Zone 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

liposomal doxorubicin 1 defactinib 1 Paclitaxel 1 Letrozole 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06072781 2026-03-17

RAMP 301

Verastem, Inc.

Phase 3 Recruiting

Low Grade Serous Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡